Amylin Pharmaceuticals


Amylin Pharmaceuticals is a biopharmaceutical company, engages in the discovery, development, and commercialization of drugs. Develops a line of diagnostic and therapeutic products for diabetics. Working towards a cure for diabetes by challenging science, changing lives. Amylin employees are dedicated in their ability to "think outside the box". Because of our commitment of constantly finding newer and better ways to treat diabetes, we come to work each day feeling like we CAN make a difference in our world.

Industries

biotechnology

Nr. of Employees

Very Large (1000+)

Amylin Pharmaceuticals

San Diego, California, United States, North America


Patents

Methods for treating diabetes and reducing body weight

US-9884092-B2

View Details

Engineered polypeptides having enhanced duration of action with reduced immunogenicity

US-9382304-B2

View Details

GLP-1 receptor agonists for islet cell transplantation

US-9161953-B2

View Details

Use of exendin and analogs thereof to delay or prevent cardiac remodeling

US-8946149-B2

View Details

Method for treating diabetes

US-8906851-B2

View Details

GIP and exendin hybrid polypeptides

US-8895498-B2

View Details
View All Patents

Similar organizations

Browse all ORGANIZATIONS

JOIN OUR MAILING LIST

Stay Connected with MTEC

Keep up with active and upcoming solicitations, MTEC news and other valuable information.